相关实验视频

Updated: Jul 1, 2026

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Published on: February 1, 2019

开发mRNA脂质纳米颗粒:向和治疗方面

Yaping Liu^1,2, Yingying Huang^1,2, Guantao He^2,3

¹College of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, China.

International journal of molecular sciences

|September 28, 2024

概括

脂质纳米粒子 (LNP) 是传递信使RNA (mRNA) 在治疗中的关键. 本综述详细介绍了LNP结构,mRNA传递和针对疾病的应用,尽管存在持续的挑战.

科学领域:

生物技术是生物技术.
纳米医学是一种纳米医学.
分子生物学分子生物学

背景情况:

使者RNA (mRNA) 疗法具有显著的潜力,但需要有效的传递系统.
脂质纳米颗粒 (LNP) 是mRNA输送的领先的非病毒载体类.
针对性传递,受控释放和稳定性的挑战阻碍了广泛的mRNA疗法应用.

研究的目的:

审查脂质纳米颗粒 (LNP) 的结构和功能,用于mRNA输送.
阐明由LNP调解的mRNA传递机制.
讨论针对性地将LNP输送到特定的细胞和组织以及它们的治疗应用.

主要方法:

文献审查侧重于LNP结构,mRNA传递机制和有针对性的传递策略.
分析mRNA-LNP技术在疫苗开发和疾病治疗中的当前应用.
确定mRNA-LNP系统的现有挑战和未来潜力.

主要成果:

临床核蛋白表现出多功能结构,使其能够有效地封装和释放mRNA.
已经实现了针对性地将mRNA-LNP传递给各种细胞类型,包括免疫细胞和肝细胞.
在传染病预防,癌症治疗和遗传疾病治疗方面,mRNA-LNP技术显示出前景.

结论:

mRNA-LNP技术是一个快速发展的领域,具有广泛的治疗潜力.
需要进一步的研究来优化输送效率,组织向,毒性概况和存储稳定性.
作为下一代基于mRNA的药物,LNP是一个有前途的平台.

关键词:

癌症癌症癌症癌症癌症遗传性疾病遗传性疾病传染病是一种传染性疾病.脂质纳米颗粒的使用方法这是mRNA疫苗.

更多相关视频

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells

Published on: June 10, 2022

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing

Published on: January 20, 2023

相关概念视频

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...